During the past decade, Shasta Regional Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shasta Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 3 trials, followed by "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Ono Pharma USA Inc" with 1 trials sponsored, "Pharmatech Oncology" with 1 trials sponsored and "SWOG Cancer Research Network" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shasta Regional Medical Center" #1 collaborator was "Cancer and Leukemia Group B" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "North Central Cancer Treatment Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Shasta Regional Medical Center" are "Adenocarcinoma of the Colon" (1 trials), "Adult Acute Basophilic Leukemia" (1 trials), "Adult Acute Eosinophilic Leukemia" (1 trials), "Adult Acute Megakaryoblastic Leukemia (M7)" (1 trials) and "Adult Acute Minimally Differentiated Myeloid Leukemia (M0)" (1 trials). Many other conditions were trialed in "Shasta Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Shasta Regional Medical Center" are "Drug" (6 trials), "Biological" (2 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "irinotecan hydrochloride" (2 trials), "Laboratory Biomarker Analysis" (1 trials), "Locally Directed Therapy" (1 trials), "ONO-2506" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shasta Regional Medical Center" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Shasta Regional Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Shasta Regional Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Shasta Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".